Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Inhaled loxapine 5 mg
DRUG
4 trials
Sponsors
Alexza Pharmaceuticals, Inc.
Conditions
Bipolar I Disorder
Patients With Schizophrenia and Acute Agitation
Schizophrenia
Phase 1
Staccato Loxapine Single Dose PK
Completed
NCT00444028
Alexza Pharmaceuticals, Inc.
Schizophrenia
Start: 2005-09-30
End: 2005-11-30
Updated: 2018-11-20
Phase 2
Staccato Loxapine in Agitation (Proof of Concept)
Completed
NCT00369577
Alexza Pharmaceuticals, Inc.
Schizophrenia
Start: 2006-08-31
End: 2007-01-31
Updated: 2018-01-02
Phase 3
Staccato Loxapine in Agitated Patients With Schizophrenia
Completed
NCT00628589
Alexza Pharmaceuticals, Inc.
Patients With Schizophrenia and Acute Agitation
Start: 2008-02-29
End: 2008-05-31
Updated: 2017-07-26
Staccato Loxapine in Agitated Patients With Bipolar Disorder
Completed
NCT00721955
Alexza Pharmaceuticals, Inc.
Bipolar I Disorder
Start: 2008-07-31
End: 2008-10-31
Updated: 2017-07-26
Related Papers
Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses.
2017-11-10
6 citations
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
2011-10-01
61 citations
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.
2011-01-01
78 citations